Etiometry 2025 Highlights and Looking Ahead to 2026

Blog

  • Delivered major platform advancements and expanded hospital adoption, informing the care of more than 425,000 patients to date.
  • Secured our 10th FDA clearance, validating enhanced cybersecurity protections for hospitals and patients.
  • Advanced the platform with deeper incorporation of high-resolution waveform data, enabling richer physiological insights at the point of care.
  • Earned the 2025 Digital Health Hub Award – Best in Class: AI in Patient Care at the HLTH conference.
  • Published a record number of clinical studies with leading institutions, strengthening evidence across pediatric and adult critical care.
  • Continued focus on our Cardiac Critical Care Solution, supporting clinicians by organizing and displaying patient data to aid decision-making in intensive care settings.
  • Added the highest number of hospitals in company history, with notable growth among major health systems.
  • Expanded internationally, strengthening our presence in Europe and the Middle East through strategic partnerships.

As Shane Cooke, President and CEO of Etiometry, noted, the platform plays a proven role in improving care quality, reducing length of stay and ICU readmissions, lowering costs, easing care team burden, and improving documentation of complications.


We are building on this momentum with a clear focus on:

  • Expanding our presence in the adult cardiac market.
  • Accelerating international expansion in Europe and the Middle East.
  • Continuing to advance solutions to help identify and manage life-threatening conditions, including cardiogenic shock, respiratory failure, and sepsis/ARDS.


Related

Do ICUs Need Both EHR and Clinical Intelligence Systems?

Most hospitals running a modern ICU have invested heavily in their EHR. The records are thorough and the system integrates billing, compliance and clinical notes into one place. So the question that hospital leaders regularly ask is a fair one: do we need anything else? The answer, for high-acuity care, is yes. Not because the […]

Etiometry Highlights New Study Linking Pre-ECMO IDO2 Trends to Neurologic Outcomes in Infants

BOSTON, Mass. – June 2, 2026 – Etiometry, a leader in AI-driven clinical intelligence, today announced new research published in Pediatric Critical Care Medicine demonstrating that impaired oxygen delivery analytics in the hours leading up to extracorporeal membrane oxygenation (ECMO) were associated with mortality and adverse neurologic outcomes in infants.  This single-center retrospective cohort study of […]